Literature DB >> 29291395

ErbB2 promotes endothelial phenotype of human left ventricular epicardial highly proliferative cells (eHiPC).

Sergey Ryzhov1, Michael P Robich2, Daniel J Roberts2, Amanda J Favreau-Lessard1, Sarah M Peterson1, Edward Jachimowicz1, Rutwik Rath1, Calvin P H Vary1, Reed Quinn3, Robert S Kramer3, Douglas B Sawyer4.   

Abstract

The adult human heart contains a subpopulation of highly proliferative cells. The role of ErbB receptors in these cells has not been studied. From human left ventricular (LV) epicardial biopsies, we isolated highly proliferative cells (eHiPC) to characterize the cell surface expression and function of ErbB receptors in the regulation of cell proliferation and phenotype. We found that human LV eHiPC express all four ErbB receptor subtypes. However, the expression of ErbB receptors varied widely among eHiPC isolated from different subjects. eHiPC with higher cell surface expression of ErbB2 reproduced the phenotype of endothelial cells and were characterized by endothelial cell-like functional properties. We also found that EGF/ErbB1 induces VEGFR2 expression, while ligands for both ErbB1 and ErbB3/4 induce expression of Tie2. The number of CD31posCD45neg endothelial cells is higher in LV biopsies from subjects with high ErbB2 (ErbB2high) eHiPC compared to low ErbB2 (ErbB2low) eHiPC. These findings have important implications for potential strategies to increase the efficacy of cell-based revascularization of the injured heart, through promotion of an endothelial phenotype in cardiac highly proliferative cells.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell biology; Cell differentiation; Myocardium; Neuregulin

Mesh:

Substances:

Year:  2017        PMID: 29291395      PMCID: PMC5926239          DOI: 10.1016/j.yjmcc.2017.12.013

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  63 in total

1.  Reactive oxygen species generation is involved in epidermal growth factor receptor transactivation through the transient oxidization of Src homology 2-containing tyrosine phosphatase in endothelin-1 signaling pathway in rat cardiac fibroblasts.

Authors:  Cheng-Hsien Chen; Tzu-Hurng Cheng; Heng Lin; Neng-Lang Shih; Yen-Ling Chen; Yee-Shiuan Chen; Ching-Feng Cheng; Wei-Shiung Lian; Tzu-Ching Meng; Wen-Ta Chiu; Jin-Jer Chen
Journal:  Mol Pharmacol       Date:  2006-01-03       Impact factor: 4.436

2.  Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway.

Authors:  I Kim; H G Kim; J N So; J H Kim; H J Kwak; G Y Koh
Journal:  Circ Res       Date:  2000 Jan 7-21       Impact factor: 17.367

3.  Local overexpression of HB-EGF exacerbates remodeling following myocardial infarction by activating noncardiomyocytes.

Authors:  Hiroaki Ushikoshi; Tomoyuki Takahashi; Xuehai Chen; Ngin Cin Khai; Masayasu Esaki; Kazuko Goto; Genzou Takemura; Rumi Maruyama; Shinya Minatoguchi; Takako Fujiwara; Satoshi Nagano; Kentaro Yuge; Takao Kawai; Yoshiteru Murofushi; Hisayoshi Fujiwara; Ken-ichiro Kosai
Journal:  Lab Invest       Date:  2005-07       Impact factor: 5.662

4.  Combined immunoelectron microscopic and computer-assisted image analyses to detect advanced glycation end-products in human myocardium.

Authors:  Cameron Donaldson; Douglas J Taatjes; Michael Zile; Bradley Palmer; Peter VanBuren; Francis Spinale; David Maughan; Michele Von Turkovich; Nicole Bishop; Martin M LeWinter
Journal:  Histochem Cell Biol       Date:  2010-05-19       Impact factor: 4.304

5.  Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis.

Authors:  K S Russell; D F Stern; P J Polverini; J R Bender
Journal:  Am J Physiol       Date:  1999-12

6.  Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart.

Authors:  Zhengxian Tao; Bo Chen; Xiao Tan; Yingming Zhao; Liansheng Wang; Tiebing Zhu; Kejiang Cao; Zhijian Yang; Yuet Wai Kan; Hua Su
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-18       Impact factor: 11.205

7.  Neuregulin-1β promotes glucose uptake via PI3K/Akt in neonatal rat cardiomyocytes.

Authors:  Laura Pentassuglia; Philippe Heim; Sonia Lebboukh; Christian Morandi; Lifen Xu; Marijke Brink
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-03-15       Impact factor: 4.310

Review 8.  Neuregulin in cardiovascular development and disease.

Authors:  Oghenerukevwe Odiete; Michael F Hill; Douglas B Sawyer
Journal:  Circ Res       Date:  2012-10-26       Impact factor: 17.367

9.  Intravenous glial growth factor 2 (GGF2) isoform of neuregulin-1β improves left ventricular function, gene and protein expression in rats after myocardial infarction.

Authors:  Michael F Hill; Amish V Patel; Abigail Murphy; Holly M Smith; Cristi L Galindo; Laura Pentassuglia; Xuyang Peng; Carrie G Lenneman; Oghenerukevwe Odiete; David B Friedman; Marvin W Kronenberg; Siyuen Zheng; Zhongming Zhao; Yanna Song; Frank E Harrell; Maya Srinivas; Anindita Ganguly; Jennifer Iaci; Tom J Parry; Anthony O Caggiano; Douglas B Sawyer
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

Review 10.  The epidermal growth factor receptor and its ligands in cardiovascular disease.

Authors:  Nader Makki; Kristina W Thiel; Francis J Miller
Journal:  Int J Mol Sci       Date:  2013-10-15       Impact factor: 5.923

View more
  4 in total

1.  High ErbB3 activating activity in human blood is not due to circulating neuregulin-1 beta.

Authors:  Emmanuel Boateng; Joanne T deKay; Sarah M Peterson; Jacob Boles; Nathan Pinnette; Mary W Sorcher; Michael P Robich; Douglas B Sawyer; Sergey Ryzhov
Journal:  Life Sci       Date:  2020-04-03       Impact factor: 5.037

2.  Large-Scale Single-Cell RNA-Seq Reveals Molecular Signatures of Heterogeneous Populations of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells.

Authors:  David T Paik; Lei Tian; Jaecheol Lee; Nazish Sayed; Ian Y Chen; Siyeon Rhee; June-Wha Rhee; Youngkyun Kim; Robert C Wirka; Jan W Buikema; Sean M Wu; Kristy Red-Horse; Thomas Quertermous; Joseph C Wu
Journal:  Circ Res       Date:  2018-08-03       Impact factor: 17.367

3.  Systemic and cardiac susceptibility of immune compromised mice to doxorubicin.

Authors:  Amanda J Favreau-Lessard; Hagen Blaszyk; Michael A Jones; Douglas B Sawyer; Ilka M Pinz
Journal:  Cardiooncology       Date:  2019-04-25

Review 4.  Neuregulins: protective and reparative growth factors in multiple forms of cardiovascular disease.

Authors:  Andrew Geissler; Sergey Ryzhov; Douglas B Sawyer
Journal:  Clin Sci (Lond)       Date:  2020-10-16       Impact factor: 6.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.